Posted on: November 17, 2016

Dr. Jochen Lorch discusses the lack of treatment options available for medullary thyroid cancer patients, as well as possible future treatment trials.

» Read More
Posted on: October 14, 2016

Ignyta is coordinating a new clinical trial for TRK mutations, which are often seen in head and neck cancer patients. The TCC works to alert patients and physicians on relevant studies to identify new treatment opportunities for all patients.

» Read More